FOLH1 and neoplasm: Similar results were obtained for [161Tb]Tb-PSMA-617 using PSMA-positive PC-3 PIP tumor cells, revealing that [161Tb]Tb-PSMA-617 was up to 3-fold more effective than [177Lu]Lu-PSMA-617 in vitro14.